Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib

Sunitinib has been approved for the treatment of advanced and/or metastatic renal cell carcinoma (RCC). Information on the dosage adjustment of sunitinib for patients undergoing hemodialysis is limited. Especially, efficacy and tolerance of sunitinib at a low dose in such patients are not fully unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Noda, Satoshi, Kageyama, Susumu, Tsuru, Teruhiko, Kubota, Shigehisa, Yoshida, Tetsuya, Okamoto, Keisei, Okada, Yusaku, Morita, Shin-ya, Terada, Tomohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: November, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531954/
https://www.ncbi.nlm.nih.gov/pubmed/23275777
http://dx.doi.org/10.1159/000345694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531954/
https://www.ncbi.nlm.nih.gov/pubmed/23275777
http://dx.doi.org/10.1159/000345694

Ejemplares similares